Marana Moonika Haahr, Jørgensen Louise von Gersdorff, Skov Jakob, Chettri Jiwan Kumar, Holm Mattsson Andreas, Dalsgaard Inger, Kania Per Walter, Buchmann Kurt
Department of Veterinary Disease Biology, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
National Veterinary Institute, Technical University of Denmark, Denmark.
PLoS One. 2017 Feb 9;12(2):e0171944. doi: 10.1371/journal.pone.0171944. eCollection 2017.
Aeromonas salmonicida subsp. salmonicida is the etiological agent of furunculosis and a major fish health problem in salmonid aquaculture worldwide. Injection vaccination with commercial mineral oil-adjuvanted bacterin vaccines has been partly successful in preventing the disease but in Danish rainbow trout (Oncorhynchus mykiss, Walbaum) aquaculture furunculosis outbreaks still occur. In this study we tested the efficacy of experimental subunit vaccines against A. salmonicida infection in rainbow trout. We utilized in silico screening of the proteome of A. salmonicida subsp. salmonicida strain A449 and identified potential protective protein antigens that were tested by in vivo challenge trial. A total of 14 proteins were recombinantly expressed in Escherichia coli and prepared in 3 different subunit vaccine combinations to immunize 3 groups of rainbow trout by intraperitoneal (i.p.) injection. The fish were exposed to virulent A. salmonicida 7 weeks after immunization. To assess the efficacy of the subunit vaccines we evaluated the immune response in fish after immunization and challenge infection by measuring the antibody levels and monitoring the survival of fish in different groups. The survival of fish at 3 weeks after challenge infection showed that all 3 groups of fish immunized with 3 different protein combinations exhibited significantly lower mortalities (17-30%) compared to the control groups (48% and 56%). The ELISA results revealed significantly elevated antibody levels in fish against several protein antigens, which in some cases were positively correlated to the survival.
杀鲑气单胞菌杀鲑亚种是疖疮病的病原体,也是全球鲑科鱼类养殖中一个主要的鱼类健康问题。使用商业矿物油佐剂菌苗进行注射疫苗接种在预防该病方面取得了部分成功,但在丹麦虹鳟(Oncorhynchus mykiss,Walbaum)养殖中,疖疮病疫情仍有发生。在本研究中,我们测试了实验性亚单位疫苗对虹鳟感染杀鲑气单胞菌的疗效。我们利用计算机筛选杀鲑气单胞菌杀鲑亚种A449菌株的蛋白质组,并鉴定了潜在的保护性蛋白抗原,这些抗原通过体内攻毒试验进行了测试。共有14种蛋白质在大肠杆菌中重组表达,并制备成3种不同的亚单位疫苗组合,通过腹腔注射免疫3组虹鳟。免疫7周后,将鱼暴露于强毒杀鲑气单胞菌。为了评估亚单位疫苗的疗效,我们通过测量抗体水平和监测不同组鱼的存活情况,评估了免疫和攻毒感染后鱼的免疫反应。攻毒感染3周后鱼的存活情况表明,与对照组(48%和56%)相比,用3种不同蛋白质组合免疫的所有3组鱼的死亡率均显著降低(17 - 30%)。ELISA结果显示,鱼体内针对几种蛋白质抗原的抗体水平显著升高,在某些情况下,这些抗体水平与存活率呈正相关。